ABBVIE BV has a total of 46 patent applications. Its first patent ever was published in 1993. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are N30 PHARMACEUTICALS INC, FREYNE EDDY JEAN EDGARD and N30 PHARMACEUTICALS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | Australia | 4 | |
#4 | Canada | 3 | |
#5 | Mexico | 3 | |
#6 | Brazil | 2 | |
#7 | Hong Kong | 2 | |
#8 | Republic of Korea | 2 | |
#9 | Malaysia | 2 | |
#10 | New Zealand | 2 | |
#11 | Singapore | 2 | |
#12 | Taiwan | 2 | |
#13 | South Africa | 2 | |
#14 | Chile | 1 | |
#15 | China | 1 | |
#16 | Colombia | 1 | |
#17 | Costa Rica | 1 | |
#18 | Dominican Republic | 1 | |
#19 | Ecuador | 1 | |
#20 | Guatemala | 1 | |
#21 | Peru | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Iwema Bakker Wouter I | 36 |
#2 | Coolen Hein K A C | 30 |
#3 | Van Dongen Maria J P | 30 |
#4 | Sliedregt Leonardus A J M | 19 |
#5 | Smid Pieter | 19 |
#6 | Den Hartog Jacobus A J | 18 |
#7 | Stoit Axel | 12 |
#8 | Hobson Adrian D | 7 |
#9 | Hobson Adrian | 6 |
#10 | Bronger Raymond | 6 |
Publication | Filing date | Title |
---|---|---|
USRE48301E | Fused heterocyclic derivatives as S1P modulators | |
TW201211051A | Spiro-piperidine derivatives as s1p modulators | |
TW201206945A | Fused heterocyclic derivatives as s1p modulators | |
AU2007312233A1 | Micellar nanoparticles of chemical substances | |
EP0670713A1 | A pharmaceutical formulation |